Marijuana Banking: What Does Sen McConnell Want? 'It's Not Over 'Till It's Over' Says Analyst

Senate Minority Leader Mitch McConnell recently targeted cannabis banking reform (SAFE Act) when he called on Democrats Charles Schumer and Nancy Pelosi to strip the pot-related language from the defense bill last week before the National Defense Authorization Act (NDAA) was revealed.

“House and Senate Democrats are still obstructing efforts to close out the NDAA by trying to jam in unrelated items with no relationship whatsoever to defense,” McConnell said on the Senate floor. “My colleagues across the aisle need to cut their unrelated hostage-taking and put a bipartisan NDAA on the floor.” 

Shortly after, McConnell crowed when Tuesday's final version of the NDAA did not contain marijuana banking reform.

“Just as Republicans insisted, just as our service members deserve, this NDAA is not getting dragged down by unrelated liberal nonsense,” McConnell said. “Good smart policies were kept in and unrelated nonsense like easier financing for illegal drugs was kept out.”

Rare Support

Cantor Fitzgerald analyst Pablo Zuanic shared some thoughts on the recent development around the SAFE Act in his Monday analyst note.

According to Zuanic, SAFE still has a chance, or “it’s not over ‘till it’s over.”

“We think SAFE would pass if Sen Schumer accepts the demands that Sen McConnell (Minority Leader), and the likes of retiring Senators (say, Sen Toomey), may have.”

The analyst pointed out that “there is something there” with McConnel specifically targeting the SAFE act twice.

“Let’s remember this is a bill co-sponsored by 42 Senators, including nine Republicans, “ Zuanic wrote. “Of course, we do not know what those demands may be. Perhaps the ask is that no Omnibus is passed and that the government stays open with continuing resolutions (CR) for another two months, with the next Congress then passing the Omnibus. In that context, could SAFE be attached to a CR, or go standalone (Curaleaf’s CURLF chairman says there is no time, but if it has the votes, we

understand otherwise)?”

The analyst noted the bill has the support of nine Republican Senators, 31 Senate Democrats and two Independents...something which rarely happens.

Omnibus Or Standalone - That Is The Question

Democrats will still try to attach SAFE to the Omnibus, no matter what McConnell said, Zuanic believes. “The bigger issue, however, is more about whether the two parties can agree on what the actual Appropriations Bill (Omnibus) looks like. All that said, we still believe the easier path is to go standalone.”

MSOs Could Benefit Without SAFE

When it comes to investing, taking a 1 to 2-year view, Zuanic says larger multi-state operators are the best options. Not ETFs necessarily, which are well capitalized and could also profit if SAFE doesn’t pass, thanks to the industry consolidation.

Even if SAFE doesn’t happen in 2023, it should end up being part of the investment conversation and offer support for pot stocks.

“If it does not pass this lame duck, it may still be moved forward by the Senate, and even though it may not be a top priority for Rep McCarthy (potential House Speaker), we think the likes of Reps Joyce, Mace, and Mast, may push for it (let’s remember SAFE passed the House the last time with almost 60% Republican support).”

Photo: Wikimedia Commons 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorCannabisM&AMarketsAnalyst Ratingscannabis reformCantor FitzgeraldMarijuana BankingPablo ZuanicSAFE ActSen McConnell
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.